Cheng Tao
- Genetics top 10%
- Genetic and Kidney Cyst Diseases 13
-
- Pediatric Urology and Nephrology Studies 8
- Fetal and Pediatric Neurological Disorders 4
- Nephrology top 10%
-
- NF-κB Signaling Pathways 4
-
- Renal and related cancers 6
-
- Nanoparticle-Based Drug Delivery 5
-
- Nanoplatforms for cancer theranostics 4
-
- Rheumatoid Arthritis Research and Therapies 4
- Co-authors
- Kyongtae T. BaeVicente E. TorresArlene B. ChapmanShaohua LiFengfeng LiJianjun ZhangWilliam M. BennettYuan Le
- Journals
- Kidney International (1 paper)Journal of the American Society of Nephrology (2 papers)Annals of Oncology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Cheng Tao
33 papers receiving 675 citations
Peers
Comparison fields: 5 of 87
- Genetics 340
- Pediatrics, Perinatology and Child Health 157
- Nephrology 45
- Cancer Research 76
- Molecular Medicine 23
Countries citing papers authored by Cheng Tao
This map shows the geographic impact of Cheng Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Tao more than expected).
Fields of papers citing papers by Cheng Tao
This network shows the impact of papers produced by Cheng Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Tao. The network helps show where Cheng Tao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng Tao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 50 | |
| 6 | 2020 | 16 | |
| 7 | 2019 | 19 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 18 | |
| 10 | 2018 | 7 | |
| 11 | 2017 | 5 | |
| 12 | 2016 | 9 | |
| 13 | 2016 | 38 | |
| 14 | 2016 | 11 | |
| 15 | 2014 | 12 | |
| 16 | 2014 | 11 | |
| 17 | 2014 | 81 | |
| 18 | 2014 | 61 | |
| 19 | 2013 | 6 | |
| 20 | 2009 | 55 |
About Cheng Tao
Cheng Tao is a scholar working on Genetics, Biomaterials and Pediatrics, Perinatology and Child Health, having authored 34 papers that have together received 685 indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (13 papers), Pediatric Urology and Nephrology Studies (8 papers), Renal and related cancers (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Nanoplatforms for cancer theranostics (4 papers), Fetal and Pediatric Neurological Disorders (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and NF-κB Signaling Pathways (4 papers). The work is most often cited by research in Genetics (340 citations), Pediatrics, Perinatology and Child Health (157 citations) and Nephrology (45 citations). Cheng Tao has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Kyongtae T. Bae, Vicente E. Torres, Arlene B. Chapman, Shaohua Li, Fengfeng Li, Jianjun Zhang, William M. Bennett, Yuan Le, Jie‐Xin Wang and Michael F. Flessner. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.